The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010
Open accessAbstract
Background: Increasing rates of prescriptions for antidepressants, antipsychotics and stimulants have been reported from various countries. Aims: To examine trends in prescriptions and the costs of all classes of psychiatric medication in England. Method: Data from the Prescription Cost Analysis 1998–2010 was examined, using linear regression analysis to examine trends. Results: Prescriptions of drugs used for mental disorders increased by 6.8% (95% CI 6.3–7.4) per year on average, in line with other drugs, but made up an increasing proportion of all prescription drug costs (P = 0.001). There were rising trends in prescriptions of all classes of psychiatric drugs, except anxiolytics and hypnotics (which did not change). Antidepressant prescriptions increased by 10% (95% CI 9.0–11) per year on average, and antipsychotics by 5.1% (95% CI 4.3–5.9). Antipsychotics overtook antidepressants as the most costly class of psychiatric medication, with costs rising 22% (95% CI 17–27) per year. Conclusions: Rising prescriptions may be partly explained by longer-term treatment and increasing population. Nevertheless, it appears that psychiatric drugs make an increasing contribution to total prescription drug costs, with antipsychotics becoming the most costly. Low-dose prescribing of some antipsychotics is consistent with other evidence that their use may not be restricted to those with severe mental illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
The Rising Prevalence of Chronic Low Back Pain
Freburger, J. K., Holmes, G. M., Agans, R. P., Jackman, A. M., Darter, J. D., Wallace, A. S., Castel, L. D., Kalsbeek, W. D., & Carey, T. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.543 · Cited by 1,507
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1032 · Cited by 724
Osborn, D. P. J., Levy, G., Nazareth, I., Petersen, I., Islam, A., & King, M. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.242 · Cited by 608
Increasing off‐label use of antipsychotic medications in the United States, 1995–2008
Alexander, G. C., Gallagher, S. A., Mascola, A., Moloney, R. M., & Stafford, R. S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2082 · Cited by 423
Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
Antipsychotic prescribing trends: a review of pharmaco‐epidemiological studies
Verdoux, H., Tournier, M., & Bégaud, B. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01425.x · Cited by 249
Trends in Medication Treatment for ADHD
Castle, L., Aubert, R. E., Verbrugge, R. R., Khalid, M., & Epstein, R. S. (2007) · Journal of Attention Disorders · doi:10.1177/1087054707299597 · Cited by 242
Cited by
Jorm, A. F., Patten, S. B., Brugha, T. S., & Mojtabai, R. (2017) · World Psychiatry · doi:10.1002/wps.20388 · Cited by 556
Influences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
Sheehan, R., Hassiotis, A., Walters, K., Osborn, D., Strydom, A., & Horsfall, L. (2015) · BMJ · doi:10.1136/bmj.h4326 · Cited by 403
Current Psychosomatic Practice
Fava, G. A., Cosci, F., & Sonino, N. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448856 · Cited by 302
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217
Metadata
- Authors
- Ilyas, S., & Moncrieff, J.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2012-05
- Volume
- 200
- Issue
- 5
- Pages
- 393-398
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2147717090
- Cited by
- 260
- References
- 20
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010. https://app.cochat.ai/papers/10.1192/bjp.bp.111.104257
- The paper
- Ilyas, S., & Moncrieff, J. (2012). Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010. British Journal of Psychiatry. https://doi.org/10.1192/bjp.bp.111.104257
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.